Hannah M Fisher1, Jamie M Jacobs2, Chloe J Taub3, Suzanne C Lechner4, John E Lewis5, Charles S Carver6, Bonnie B Blomberg7, Michael H Antoni8. 1. Department of Psychology, University of Miami, Coral Gables, FL 33124, United States. Electronic address: hannah.fisher@miami.edu. 2. Massachusetts General Hospital, Center for Psychiatric Oncology and Behavioral Sciences, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States. 3. Department of Psychology, University of Miami, Coral Gables, FL 33124, United States. 4. Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States. 5. Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States. 6. Department of Psychology, University of Miami, Coral Gables, FL 33124, United States; Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States. 7. Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States; Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL 33136, United States. 8. Department of Psychology, University of Miami, Coral Gables, FL 33124, United States; Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States.
Abstract
OBJECTIVE:Physical activity (PA) following surgery for breast cancer may improve depressive symptoms and quality of life (QoL) via reduction in fatigue-related daily interference (FRDI). Less is known about how change in PA may relate to these psychosocial factors throughout the course of treatment. In a secondary analysis of a previous psychosocial intervention trial, we examined relationships between change in PA, depressive symptoms, and functional QoL, as mediated by change in FRDI, and whether naturally occurring change in PA provided benefit independent of the intervention. METHOD: Women (N=240) with non-metastatic stage 0-III breast cancer were randomized to cognitive-behavioral stress management (CBSM) or a control 2-10weeks post-surgery. PA, FRDI, clinician-rated depressive symptoms, self-reported depressed mood, and functional QoL were assessed at baseline and three months post-intervention. RESULTS: Increased PA was associated with reductions in clinician-rated depressive symptoms, depressed mood, and improved QoL, mediated by a reduction in FRDI. This was above and beyond the effect of CBSM. CONCLUSIONS: Increased PA may mitigate FRDI and improve depressive symptoms and functional QoL for women undergoing breast cancer treatment, beyond effects of a psychosocial intervention. Benefits of an integrated PA and psychosocial approach should be investigated further.
RCT Entities:
OBJECTIVE: Physical activity (PA) following surgery for breast cancer may improve depressive symptoms and quality of life (QoL) via reduction in fatigue-related daily interference (FRDI). Less is known about how change in PA may relate to these psychosocial factors throughout the course of treatment. In a secondary analysis of a previous psychosocial intervention trial, we examined relationships between change in PA, depressive symptoms, and functional QoL, as mediated by change in FRDI, and whether naturally occurring change in PA provided benefit independent of the intervention. METHOD:Women (N=240) with non-metastatic stage 0-III breast cancer were randomized to cognitive-behavioral stress management (CBSM) or a control 2-10weeks post-surgery. PA, FRDI, clinician-rated depressive symptoms, self-reported depressed mood, and functional QoL were assessed at baseline and three months post-intervention. RESULTS: Increased PA was associated with reductions in clinician-rated depressive symptoms, depressed mood, and improved QoL, mediated by a reduction in FRDI. This was above and beyond the effect of CBSM. CONCLUSIONS: Increased PA may mitigate FRDI and improve depressive symptoms and functional QoL for women undergoing breast cancer treatment, beyond effects of a psychosocial intervention. Benefits of an integrated PA and psychosocial approach should be investigated further.
Authors: Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu Journal: Cochrane Database Syst Rev Date: 2012-08-15
Authors: Victoria Mock; Constantine Frangakis; Nancy E Davidson; Mary E Ropka; Mary Pickett; Barbara Poniatowski; Kerry J Stewart; Lane Cameron; Kristin Zawacki; Laura J Podewils; Gary Cohen; Ruth McCorkle Journal: Psychooncology Date: 2005-06 Impact factor: 3.894
Authors: M Carayol; P Bernard; J Boiché; F Riou; B Mercier; F Cousson-Gélie; A J Romain; C Delpierre; G Ninot Journal: Ann Oncol Date: 2012-10-05 Impact factor: 32.976
Authors: Sandra C Hayes; Sheree Rye; Tracey Disipio; Patsy Yates; John Bashford; Chris Pyke; Christobel Saunders; Diana Battistutta; Elizabeth Eakin Journal: Breast Cancer Res Treat Date: 2012-11-09 Impact factor: 4.872
Authors: Maíra Tristão Parra; Naghmeh Esmeaeli; Jordan Kohn; Brook L Henry; Stephen Klagholz; Shamini Jain; Christopher Pruitt; Daniel Vicario; Wayne Jonas; Paul J Mills Journal: Integr Cancer Ther Date: 2020 Jan-Dec Impact factor: 3.279